Chinese Lab Sequenced COVID-19 Weeks Before Beijing Disclosed Data

A China-based researcher had already mapped the COVID-19 sequence two weeks before China’s ruling communist regime revealed such details to the world, raising questions about what other crucial pandemic information Beijing may have buried from view.

At the time, Chinese authorities were still calling the disease an unknown pneumonia and ordered health workers not to spread any information around it with threat of penalty.

National Institutes of Health’s (NIH’s) GenBank repository, which received the data from Ms. Ren, notified the Chinese virologist that the submission was “incomplete” and “lacked the necessary information required for publication,” the Department of Health and Human Services told the House committee in a letter.

Following a quality review process that screens for technical details, the GenBank asked for additional information from Ms. Ren, who works at the state-run Institute of Pathogen Biology, but never heard back, leading to the sequence’s removal from the database on Jan. 16, 2020. During this period, GenBank received a near-identical COVID-19 genetic sequence from a different submitter, which it published on Jan. 12, 2020, according to the letter that the Energy and Commerce Committee released on Jan. 17 this year.

Related Stories

In contrast with the Chinese regime’s insistence that it has been transparent on the COVID origin issue, the newly unearthed information suggested otherwise, Committee Republicans said.

“This significant discovery further underscores why we cannot trust any of the so-called ‘facts’ or data provided by the CCP (Chinese Communist Party) and calls into serious question the legitimacy of any scientific theories based on such information,” committee chair McMorris Rodgers (R-Wash.), Subcommittee on Health chair Brett Guthrie (R-Ky.), and Subcommittee on Oversight and Investigations chair Morgan Griffith (R-Va.), said in a joint statement.

“The American people deserve to know the truth about the origins of SARS-CoV-2, and our investigation has uncovered numerous causes for concern, including how taxpayers’ dollars are spent, how our government’s public health agencies operate, and the need for more oversight into research grants to foreign scientists.”

The virus genome data that Ms. Ren submitted, the earliest kind known by far, appears to have come from a 65-year-old Chinese deliveryman, who was hospitalized with high fever and coughing on Dec. 18 and became critically ill four days later.

“In terms of how I see this whole incident, most of all is disappointment, pain, and anger. We had been so timely on this, how come it’s still not under control?” the person wrote on Chinese social media. “It has less to do with science or technology, and more with policy and media.” A Chinese media report citing the incident has been deleted.

Ms. Ren has led the discovery of several emerging viruses in China, including human rhinovirus A21 subvariant, and, like other prominent Chinese virology researchers, has come out in defense of the CCP on the virus origin issue.

In correspondence from September 2021, now published in the medical journal Lancet, Ms. Ren and over a dozen other Chinese medical researchers dismissed the chances that the virus may have leaked from Wuhan Institute of Virology—another EcoHealth subgrantee that had, for years, been working on dangerous bat coronaviruses—demanding instead that the origins of COVID-19 would best be “investigated worldwide.”

Chinese media have lauded her role in isolating and synthesizing the virus genome, citing approving statements from the World Health Organization that lent her credence. Ms. Ren’s work was recognized by the Chinese Academy of Medical Sciences—the highest state-level Chinese medical research institute that her research center is affiliated with—as one of 40 “major national medical developments of the year.”

Scrutiny has increased over the lab leak possibility.